[
  {
    "ts": null,
    "headline": "IHE: Healthcare Dashboard For June",
    "summary": "This is our monthly dashboard series on Healthcare and Pharma stocks. Read the full analysis here, and which 10 healthcare stocks were cheaper than their peers in June 2025.",
    "url": "https://finnhub.io/api/news?id=5bd3d37037c925aa23d9d9138ebe7c3a09ec14b7fca953591a7be9042018cd10",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1750253083,
      "headline": "IHE: Healthcare Dashboard For June",
      "id": 135370933,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/901284104/image_901284104.jpg?io=getty-c-w1536",
      "related": "JNJ",
      "source": "SeekingAlpha",
      "summary": "This is our monthly dashboard series on Healthcare and Pharma stocks. Read the full analysis here, and which 10 healthcare stocks were cheaper than their peers in June 2025.",
      "url": "https://finnhub.io/api/news?id=5bd3d37037c925aa23d9d9138ebe7c3a09ec14b7fca953591a7be9042018cd10"
    }
  },
  {
    "ts": null,
    "headline": "Should You Invest in the Invesco Pharmaceuticals ETF (PJP)?",
    "summary": "Sector ETF report for PJP",
    "url": "https://finnhub.io/api/news?id=f193afb4bc75857dc117197bde8a01acb07e9b2041e0a93a74fb367688559d03",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1750242007,
      "headline": "Should You Invest in the Invesco Pharmaceuticals ETF (PJP)?",
      "id": 135353659,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "Sector ETF report for PJP",
      "url": "https://finnhub.io/api/news?id=f193afb4bc75857dc117197bde8a01acb07e9b2041e0a93a74fb367688559d03"
    }
  },
  {
    "ts": null,
    "headline": "Johnson & Johnson rolls out TECNIS Odyssey IOL in selected regions",
    "summary": "The TECNIS Odyssey IOL aims to enhance visual freedom, providing accurate vision for activities such as reading and driving.",
    "url": "https://finnhub.io/api/news?id=4718bd9b41010c0b88eb08d95a7f502840764f00c9c5ead55ccb6a75a60d56f2",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1750237547,
      "headline": "Johnson & Johnson rolls out TECNIS Odyssey IOL in selected regions",
      "id": 135357628,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "The TECNIS Odyssey IOL aims to enhance visual freedom, providing accurate vision for activities such as reading and driving.",
      "url": "https://finnhub.io/api/news?id=4718bd9b41010c0b88eb08d95a7f502840764f00c9c5ead55ccb6a75a60d56f2"
    }
  },
  {
    "ts": null,
    "headline": "2 Dividend Stocks to Buy and Never Sell",
    "summary": "Johnson & Johnson has an impressive streak of payout increases, indicating a robust business.  Merck is facing challenges, but it can overcome them through innovation.  There are excellent reasons to invest in dividend stocks, including the fact that they typically outperform their non-dividend-paying peers in delivering strong market returns over long periods.",
    "url": "https://finnhub.io/api/news?id=225e7c9ce680b5d6e2261385c2f4a219dc504de80134b49ad16408241ae51e24",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1750237320,
      "headline": "2 Dividend Stocks to Buy and Never Sell",
      "id": 135357631,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "Johnson & Johnson has an impressive streak of payout increases, indicating a robust business.  Merck is facing challenges, but it can overcome them through innovation.  There are excellent reasons to invest in dividend stocks, including the fact that they typically outperform their non-dividend-paying peers in delivering strong market returns over long periods.",
      "url": "https://finnhub.io/api/news?id=225e7c9ce680b5d6e2261385c2f4a219dc504de80134b49ad16408241ae51e24"
    }
  },
  {
    "ts": null,
    "headline": "Move Over Hims & Hers Health: This Insurance Business Could Be the Next Monster Healthcare Stock (Hint: It's Not UnitedHealth)",
    "summary": "Hims & Hers Health shares rocketed higher over the last year, rewarding investors.",
    "url": "https://finnhub.io/api/news?id=8645a39cfccb91d25054cf6b9af779bd36c85a38e2cd67f28d569e6ebe5599d2",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1750234800,
      "headline": "Move Over Hims & Hers Health: This Insurance Business Could Be the Next Monster Healthcare Stock (Hint: It's Not UnitedHealth)",
      "id": 135349674,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "Hims & Hers Health shares rocketed higher over the last year, rewarding investors.",
      "url": "https://finnhub.io/api/news?id=8645a39cfccb91d25054cf6b9af779bd36c85a38e2cd67f28d569e6ebe5599d2"
    }
  }
]